Optimizing Immunotherapy Selection in Advanced or Metastatic Melanoma: Balancing Efficacy and Safety Across Practice Settings

home / around-the-practice / optimizing-immunotherapy-selection-in-advanced-or-metastatic-melanoma-balancing-efficacy

Leading oncology experts come together for an in-depth virtual roundtable on immunotherapy strategies in advanced or metastatic melanoma. Moderated by Dr. Douglas B. Johnson of Vanderbilt University Medical Center, and joined by distinguished panelists Dr. Ahmad Tarhini (Moffitt Cancer Center) and Dr. Yana G. Najjar (University of Pittsburgh Medical Center), the series explores the evolving treatment landscape with a focus on real-world application, efficacy, and patient safety.